Stocks TelegraphStocks Telegraph
Stock Ideas

BNTC Financial Statements and Analysis

NASDAQ : BNTC

Benitec Biopharma

$12.18
0.23+1.92%
At Close 4:00 PM
67.67
B-ESG ScoreESG Rating

FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024
reported currencyUSDUSDUSDUSDUSD
calendar year20262026202520252025
periodQ2Q1Q4Q3Q2
revenue00556.00K00
cost of revenue120.00K118.00K278.00K106.00K81.00K
gross profit-120.00K-118.00K278.00K-106.00K-81.00K
gross profit ratio000.5000
research and development expenses5.834M3.37M3.695M5.98M5.072M
general and administrative expenses0013.481M00
selling and marketing expenses00000
selling general and administrative expenses7.423M6.315M13.481M4.102M3.457M
other expenses00278.00K00
operating expenses13.257M9.685M17.454M10.082M8.529M
cost and expenses13.377M9.803M17.732M10.188M8.61M
interest income1.39M1.011M1.036M823.00K823.00K
interest expense00000
depreciation and amortization14.00K118.00K-278.00K106.00K81.00K
ebitda-13.377M-9.685M-19.02M-9.248M-7.276M
ebitda ratio00-34.20900
operating income-13.377M-9.803M-17.176M-10.188M-8.61M
operating income ratio00-30.89200
total other income expenses net1.54M838.00K1.029M834.00K1.253M
income before tax-11.837M-8.965M-16.147M-9.354M-7.357M
income before tax ratio00-29.04100
income tax expense00000
net income-11.837M-8.965M-16.147M-9.354M-7.357M
net income ratio00-29.04100
eps-0.26-0.22-0.39-0.24-0.33
eps diluted-0.26-0.22-0.39-0.24-0.33
weighted average shs out45.971M41.521M36.209M38.599M22.075M
weighted average shs out dil45.971M41.521M36.209M38.599M22.075M
Graph

Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024
reported currencyUSDUSDUSDUSDUSD
calendar year20262026202520252025
periodQ2Q1Q4Q3Q2
cash and cash equivalents188.79M94.479M97.744M103.583M78.283M
short term investments00000
cash and short term investments188.79M94.479M97.744M103.583M78.283M
net receivables130.00K7.00K33.00K3.00K2.00K
inventory00000
other current assets675.00K593.00K741.00K424.00K428.00K
total current assets189.595M95.079M98.518M104.01M78.713M
property plant equipment net1.02M873.00K991.00K1.109M288.00K
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets66.00K75.00K83.00K90.00K67.00K
total non current assets1.086M948.00K1.074M1.199M355.00K
other assets00000
total assets190.681M96.027M99.592M105.209M79.068M
account payables1.016M271.00K201.00K433.00K593.00K
short term debt468.00K414.00K354.00K346.00K137.00K
tax payables00000
deferred revenue00000
other current liabilities1.317M1.34M1.247M6.247M2.359M
total current liabilities2.801M2.025M1.802M7.026M3.089M
long term debt519.00K403.00K495.00K613.00K0
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities000038.00K
total non current liabilities519.00K403.00K495.00K613.00K38.00K
other liabilities00000
capital lease obligations987.00K817.00K849.00K959.00K137.00K
total liabilities3.32M2.428M2.297M7.639M3.127M
preferred stock00000
common stock3.00K2.00K2.00K2.00K2.00K
retained earnings-248.978M-237.141M-228.176M-212.029M-202.675M
accumulated other comprehensive income loss-883.00K-750.00K-839.00K-716.00K-688.00K
other total stockholders equity437.219M331.488M326.308M310.313M279.302M
total stockholders equity187.361M93.599M97.295M97.57M75.941M
total equity187.361M93.599M97.295M97.57M75.941M
total liabilities and stockholders equity190.681M96.027M99.592M105.209M79.068M
minority interest00000
total investments00000
total debt987.00K817.00K849.00K959.00K137.00K
net debt-187.803M-93.662M-96.895M-102.624M-78.146M
Graph

Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024
reported currencyUSDUSDUSDUSDUSD
calendar year20262026202520252025
periodQ2Q1Q4Q3Q2
deferred income tax00000
stock based compensation7.379M5.18M02.597M943.00K
change in working capital-139.011K190.793K-5.503M659.00K-606.00K
accounts receivables123.01K29.967K-22.851K00
inventory00000
accounts payables00-5.113M00
other working capital-262.021K160.825K-367.026K659.00K-606.00K
other non cash items701.011K125.206K5.661M2.906M-764.00K
net cash provided by operating activities-3.776M-3.351M-8.529M-3.086M-7.703M
investments in property plant and equipment-11.00K0-466.00-18.00K-12.00K
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites00012.00K0
net cash used for investing activites-11.00K0-466.00-6.00K-12.00K
debt repayment00000
common stock issued98.409M04.279M26.489M17.874M
common stock repurchased00000
dividends paid00000
other financing activites-178.701K001.925M-2.00K
net cash used provided by financing activities98.23M04.279M28.414M17.872M
effect of forex changes on cash-132.00K86.00K-1.539M-21.00K283.00K
net change in cash94.311M-3.265M-5.789M25.301M10.44M
cash at end of period188.903M94.592M97.857M103.646M78.345M
cash at beginning of period94.592M97.857M103.646M78.345M67.905M
operating cashflow-3.776M-3.351M-8.529M-3.086M-7.703M
capital expenditure-11.00K0-471.00-6.00K-12.00K
free cash flow-3.787M-3.351M-8.529M-3.092M-7.715M
Graph

Frequently Asked Questions

How did Benitec Biopharma Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, BNTC generated $0.00 in revenue last quarter, while its costs came in at $120.00K.
Last quarter, how much Gross Profit did Benitec Biopharma Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Benitec Biopharma Inc. reported a -$120.00K Gross Profit for the quarter ended Dec 31, 2025.
Have BNTC's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. BNTC incurred $13.26M worth of Operating Expenses, while it generated -$13.38M worth of Operating Income.
How much Net Income has BNTC posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Benitec Biopharma Inc., the company generated -$11.84M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Benitec Biopharma Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Benitec Biopharma Inc. as of the end of the last quarter was $188.79M.
What are BNTC's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, BNTC had Total Net Receivables of $130.00K.
In terms of Total Assets and Current Assets, where did Benitec Biopharma Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of BNTC were $189.60M, while the Total Assets stand at $190.68M.
As of the last quarter, how much Total Debt did Benitec Biopharma Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of BNTC's debt was $987.00K at the end of the last quarter.
What were BNTC's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, BNTC reported total liabilities of $3.32M.
How much did BNTC's Working Capital change over the last quarter?
Working Capital Change for BNTC was -$139.01K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
BNTC generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. BNTC generated -$3.78M of Cash from Operating Activities during its recently reported quarter.
What was BNTC's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. BNTC reported a $94.31M Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph